LEADER 00873nam0-22003011i-450-
001 990000667350403321
005 20120528110743.0
035   $a000066735
035   $aFED01000066735
035   $a(Aleph)000066735FED01
035   $a000066735
100   $a20020821d1969----km-y0itay50------ba
101 0 $aeng
102   $aGB
105   $aa---c---001yy
200 1 $aArchitecture and society$eselected assays of Henry van Brunt$fedited with an introductory monograph by William A. Coles
210   $aCambridge$cBelknap Press$d1969
215   $aX, 562 p.$cill.$d25 cm
702  1$aColes,$bWilliam A.
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990000667350403321
952   $a01 DA 2063$b02723$fDINST
952   $a07.151$b5618$fDARST
959   $aDINST
959   $aDARST
996   $aArchitecture and society$9326226
997   $aUNINA

LEADER 01070nam a22002651i 4500
001 991000441529707536
005 20040909071712.0
008 040920s1996    it                  ita  
020   $a9788813199722 (v. 2)
035   $ab13221498-39ule_inst
035   $aARCHE-116772$9ExL
040   $aSet. Economia$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l.
082 04$a658
100 1 $aCeccanti, Gastone$0108661
245 10$aCorso di tecnica imprenditoriale /$cGastone Ceccanti
260   $aPadova :$bCEDAM,$c1996
300   $av. ;$c25 cm
505 0 $g2.:$tPiani operativi e di sviluppo, regolazione, governo e direzione per obiettivi. - Padova : Cedam, 1996.$g- XIII, 484 p
650  4$aAziende$xGestione
907   $a.b13221498$b13-03-19$c23-09-04
912   $a991000441529707536
945   $aLE025 ECO 658 CEC01.01$cV. 2$g1$i2025000171169$lle025$nCatalogato 2019$o-$pE0.00$q-$rl$s-  $t0$u1$v0$w1$x0$y.i13878268$z23-09-04
996   $aCorso di tecnica imprenditoriale$9888467
997   $aUNISALENTO
998   $ale025$b23-09-04$cm$da  $e-$fita$git $h0$i1

LEADER 02421nas  2200697-a 450 
001 9910985992103321
005 20260127110736.0
011   $a1744-8379
035   $a(DE-599)ZDB2090846-5
035   $a(CKB)111056648275076
035   $a(CONSER)--2002243429
035   $a(MiFhGG)3GLY
035   $a(DE-599)2090846-5
035   $a(EXLCZ)99111056648275076
100   $a20011114a20019999  ---         -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aExpert review of pharmacoeconomics & outcomes research
210   $aLondon $cFuture Drugs Ltd.$d[2001]-
210 21$aLondon :$cInforma Healthcare
210 31$aAbingdon, Oxford :$cTaylor & Francis
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aTitle from cover.
311 08$aPrint version: Expert review of pharmacoeconomics & outcomes research. (DLC)  2002243429 (OCoLC)50638419 1473-7167 
531   $aEXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH
531   $aEXPERT REV PHARMACOECON OUTCOMES RES
531   $aEXPERT REV. PHARMACOECON. OUTCOMES RES
531   $aEXPERT REV PHARM OUT
531 0 $aExpert rev. pharmacoecon. outcomes res.
606   $aDrugs$xCosts$vPeriodicals
606   $aChemotherapy$xEconomic aspects
606   $aPharmacology$xEconomic aspects$vPeriodicals
606   $aEconomics, Pharmaceutical
606   $aCost-Benefit Analysis
606   $aDecision Making
606   $aDrug Therapy$xeconomics
606   $aOutcome Assessment, Health Care
606   $aChemotherapy$xEconomic aspects$2fast$3(OCoLC)fst00853599
606   $aDrugs$xCosts$2fast$3(OCoLC)fst00898787
608   $aPeriodical.
608   $aReview.
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
615  0$aDrugs$xCosts
615  0$aChemotherapy$xEconomic aspects.
615  0$aPharmacology$xEconomic aspects
615 12$aEconomics, Pharmaceutical.
615 22$aCost-Benefit Analysis.
615 22$aDecision Making.
615 22$aDrug Therapy$xeconomics.
615 22$aOutcome Assessment, Health Care.
615  7$aChemotherapy$xEconomic aspects.
615  7$aDrugs$xCosts.
906   $aJOURNAL
912   $a9910985992103321
920   $aexl_impl conversion
996   $aExpert review of pharmacoeconomics & outcomes research$92381170
997   $aUNINA